MeSH Browser

MeSH Heading: Muscarinic Antagonists
Tree Number(s): D27.505.519.625.120.200.500; D27.505.696.577.120.200.500
Unique ID: D018727
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D018727
Scope Note: Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
Entry Version: MUSCARINIC ANTAG
Entry Term(s): Antimuscarinic; Antimuscarinic Agent; Antimuscarinic Agents; Antimuscarinics; Cholinergic Muscarinic Antagonist; Cholinergic Muscarinic Antagonists; Muscarinic Antagonist
Registry Number: 0
NLM Classification #: QV 132
Previous Indexing: Parasympatholytics (1966-1994)
See Also: Parasympatholytics
Public MeSH Note: 95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94
Online Note: use PARASYMPATHOLYTICS to search ANTIMUSCARINIC AGENTS 1969-94
History Note: 95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94
Date Established: 1995/01/01
Date of Entry: 1994/06/01
Revision Date: 2020/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0028057
Registry Number: 0
Scope Note: Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
Terms: Muscarinic Antagonists Preferred Term
Term UI T055778
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1995); Antimuscarinic
Term UI T000996623
Date11/15/2019
LexicalTag NON
ThesaurusID NLM (2021); Cholinergic Muscarinic Antagonist
Term UI T000996626
Date11/15/2019
LexicalTag NON
ThesaurusID NLM (2021); Antimuscarinic Agent
Term UI T000996625
Date11/15/2019
LexicalTag NON
ThesaurusID NLM (2021); Antimuscarinic Agents
Term UI T055777
Date02/07/1994
LexicalTag NON
ThesaurusID NLM (1995); Antimuscarinics
Term UI T758362
Date09/24/2009
LexicalTag NON
ThesaurusID NLM (2011); Cholinergic Muscarinic Antagonists
Term UI T848581
Date08/29/2013
LexicalTag NON
ThesaurusID NLM (2015); Muscarinic Antagonist
Term UI T000996624
Date11/15/2019
LexicalTag NON
ThesaurusID NLM (2021)

Muscarinic Antagonists MeSH Descriptor Data 2023